HIGHLIGHTS
- who: Anthony Rooney from the patients who received care at the University of Kansas KS, USA have published the research work: Risk of SARS-CoV-2 Breakthrough Infection in Vaccinated Cancer Patients: A Retrospective Cohort Study, in the Journal: (JOURNAL)
SUMMARY
During this period, all patients receiving anti-neoplastic therapy were required to have SARSCoV-2 testing via nasopharyngeal RT-PCR prior to each new treatment cycle. Patients not receiving antineoplastic therapy were screened for COVID symptoms and underwent nasopharyngeal RT-PCR testing if they screened positive. Patients who received both doses of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.